Financhill
Back

Innate Pharma SA Stock Price Chart

Don't put a penny in AI stocks until you read this

Discover this under-the-radar AI stock now, ahead of the crowd.
Sell
27

IPHA
Innate Pharma SA

Last Price:
1.98
Seasonality Move:
19.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Multimillionaire Trader Reveals His #1 Gold Pick

Click here to learn more about this game-changing opportunity.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Innate Pharma SA Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.06 Buy
20-day SMA: 2.15 Sell
50-day SMA: 2.22 Sell
200-day SMA: 2.42 Sell
8-day EMA: 2.08 Buy
20-day EMA: 2.13 Sell
50-day EMA: 2.19 Sell
200-day EMA: 2.38 Sell

Innate Pharma SA Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 46.91 Sell
Chaikin Money Flow: 3942 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.08 - 2.24) Sell
Bollinger Bands (100): (2.03 - 2.47) Sell

Innate Pharma SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Innate Pharma SA Stock

Is Innate Pharma SA Stock a Buy?

  • Innate Pharma SA share price is 2.10 while IPHA 8-day simple moving average is 2.06, which is a Buy signal.
  • The stock price of IPHA is 2.10 while Innate Pharma SA 20-day SMA is 2.15, which makes it a Sell.
  • Innate Pharma SA 50-day simple moving average is 2.22 while IPHA share price is 2.10, making it a Sell technically.
  • IPHA stock price is 2.10 and Innate Pharma SA 200-day simple moving average is 2.42, creating a Sell signal.

IPHA Technical Analysis vs Fundamental Analysis

Sell
27
Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy or a Sell?

  • Innate Pharma SA stock is rated a Sell
    The current Innate Pharma SA [IPHA] share price is $2.10. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.

Innate Pharma SA Stock Info

Market Cap:
170M
Price in USD:
2.10
Share Volume:
3.94K

Innate Pharma SA 52-Week Range

52-Week High:
3.15
52-Week Low:
1.81
Sell
27
Innate Pharma SA (IPHA) is a Sell

Innate Pharma SA Share Price Forecast

Is Innate Pharma SA Stock a Buy?

  • Innate Pharma SA share price is 2.10 while IPHA 8-day exponential moving average is 2.08, which is a Buy signal.
  • The stock price of IPHA is 2.10 while Innate Pharma SA 20-day EMA is 2.13, which makes it a Sell.
  • Innate Pharma SA 50-day exponential moving average is 2.19 while IPHA share price is 2.10, making it a Sell technically.
  • IPHA stock price is 2.10 and Innate Pharma SA 200-day simple moving average is 2.38, creating a Sell signal.

Fundamental Analysis of Innate Pharma SA

Is Innate Pharma SA a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Innate Pharma SA

Should I short Innate Pharma SA stock?

* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.